Literature DB >> 23707685

Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 Å cocrystal structure of gp120 and M48U1.

Priyamvada Acharya1, Timothy S Luongo, Mark K Louder, Krisha McKee, Yongping Yang, Young Do Kwon, John R Mascola, Pascal Kessler, Loïc Martin, Peter D Kwong.   

Abstract

The interface between the HIV-1 gp120 envelope glycoprotein and the CD4 receptor contains an unusual interfacial cavity, the "Phe43 cavity", which CD4-mimetic miniproteins with nonnatural extensions can potentially utilize to enhance their neutralization of HIV-1. Here, we report cocrystal structures of HIV-1 gp120 with miniproteins M48U1 and M48U7, which insert cyclohexylmethoxy and 5-hydroxypentylmethoxy extensions, respectively, into the Phe43 cavity. Both inserts displayed flexibility and hydrophobic interactions, but the M48U1 insert showed better shape complementarity with the Phe43 cavity than the M48U7 insert. Subtle alteration in the gp120 conformation played a substantial role in optimizing fit. With M48U1, these translated into a YU2-gp120 affinity of 0.015 nM and neutralization of all 180 circulating HIV-1 strains tested, except clade-A/E isolates with noncanonical Phe43 cavities. Ligand chemistry, shape complementarity, surface burial, and gp120 conformation act in concert to modulate binding of ligands to the gp120-Phe43 cavity and, when optimized, can effect near-pan-neutralization of HIV-1.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707685      PMCID: PMC4140785          DOI: 10.1016/j.str.2013.04.015

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  38 in total

1.  Energetics of the HIV gp120-CD4 binding reaction.

Authors:  D G Myszka; R W Sweet; P Hensley; M Brigham-Burke; P D Kwong; W A Hendrickson; R Wyatt; J Sodroski; M L Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies.

Authors:  James Arthos; Claudia Cicala; Tavis D Steenbeke; Tae-Wook Chun; Charles Dela Cruz; Douglas B Hanback; Prateeti Khazanie; Daniel Nam; Peter Schuck; Sara M Selig; Donald Van Ryk; Margery A Chaikin; Anthony S Fauci
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

3.  Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.

Authors:  Moses Prabu-Jeyabalan; Ellen Nalivaika; Celia A Schiffer
Journal:  Structure       Date:  2002-03       Impact factor: 5.006

4.  HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.

Authors:  Peter D Kwong; Michael L Doyle; David J Casper; Claudia Cicala; Stephanie A Leavitt; Shahzad Majeed; Tavis D Steenbeke; Miro Venturi; Irwin Chaiken; Michael Fung; Hermann Katinger; Paul W I H Parren; James Robinson; Donald Van Ryk; Liping Wang; Dennis R Burton; Ernesto Freire; Richard Wyatt; Joseph Sodroski; Wayne A Hendrickson; James Arthos
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

5.  A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease.

Authors:  Sonia Vega; Lin-Woo Kang; Adrian Velazquez-Campoy; Yoshiaki Kiso; L Mario Amzel; Ernesto Freire
Journal:  Proteins       Date:  2004-05-15

6.  Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.

Authors:  C Vita; E Drakopoulou; J Vizzavona; S Rochette; L Martin; A Ménez; C Roumestand; Y S Yang; L Ylisastigui; A Benjouad; J C Gluckman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

7.  Combating susceptibility to drug resistance: lessons from HIV-1 protease.

Authors:  Nancy M King; Moses Prabu-Jeyabalan; Ellen A Nalivaika; Celia A Schiffer
Journal:  Chem Biol       Date:  2004-10

8.  Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes.

Authors:  Loïc Martin; François Stricher; Dorothée Missé; Francesca Sironi; Martine Pugnière; Philippe Barthe; Rafael Prado-Gotor; Isabelle Freulon; Xavier Magne; Christian Roumestand; André Ménez; Paolo Lusso; Francisco Veas; Claudio Vita
Journal:  Nat Biotechnol       Date:  2002-12-16       Impact factor: 54.908

9.  Shape complementarity at protein/protein interfaces.

Authors:  M C Lawrence; P M Colman
Journal:  J Mol Biol       Date:  1993-12-20       Impact factor: 5.469

Review 10.  Enfuvirtide.

Authors:  Ray Y Chen; J Michael Kilby; Michael S Saag
Journal:  Expert Opin Investig Drugs       Date:  2002-12       Impact factor: 6.206

View more
  21 in total

Review 1.  HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.

Authors:  Priyamvada Acharya; Sabrina Lusvarghi; Carole A Bewley; Peter D Kwong
Journal:  Expert Opin Ther Targets       Date:  2015-02-27       Impact factor: 6.902

2.  Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.

Authors:  Weizao Chen; Yang Feng; Ponraj Prabakaran; Tianlei Ying; Yanping Wang; Jianping Sun; Camila D S Macedo; Zhongyu Zhu; Yuxian He; Victoria R Polonis; Dimiter S Dimitrov
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

3.  Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.

Authors:  Laurence Meyer; Francis Barin; Mélanie Bouvin-Pley; Maxime Beretta; Alain Moreau; Emmanuelle Roch; Asma Essat; Cécile Goujard; Marie-Laure Chaix; Nathalie Moiré; Loïc Martin; Martine Braibant
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.

Authors:  Saina Beitari; Qinghua Pan; Andrés Finzi; Chen Liang
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

5.  CD4 mimetics sensitize HIV-1-infected cells to ADCC.

Authors:  Jonathan Richard; Maxime Veillette; Nathalie Brassard; Shilpa S Iyer; Michel Roger; Loïc Martin; Marzena Pazgier; Arne Schön; Ernesto Freire; Jean-Pierre Routy; Amos B Smith; Jongwoo Park; David M Jones; Joel R Courter; Bruno N Melillo; Daniel E Kaufmann; Beatrice H Hahn; Sallie R Permar; Barton F Haynes; Navid Madani; Joseph G Sodroski; Andrés Finzi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

6.  Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.

Authors:  Neelakshi Gohain; William D Tolbert; Priyamvada Acharya; Lei Yu; Tongyun Liu; Pingsen Zhao; Chiara Orlandi; Maria L Visciano; Roberta Kamin-Lewis; Mohammad M Sajadi; Loïc Martin; James E Robinson; Peter D Kwong; Anthony L DeVico; Krishanu Ray; George K Lewis; Marzena Pazgier
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

7.  Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoprotein.

Authors:  Laurence Morellato-Castillo; Priyamvada Acharya; Olivier Combes; Johan Michiels; Anne Descours; Oscar H P Ramos; Yongping Yang; Guido Vanham; Kevin K Ariën; Peter D Kwong; Loïc Martin; Pascal Kessler
Journal:  J Med Chem       Date:  2013-06-11       Impact factor: 7.446

8.  Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors.

Authors:  Annemarie Laumaea; Amos B Smith; Joseph Sodroski; Andrés Finzi
Journal:  Curr Opin HIV AIDS       Date:  2020-09       Impact factor: 4.283

9.  Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.

Authors:  Priyamvada Acharya; William D Tolbert; Neelakshi Gohain; Xueji Wu; Lei Yu; Tongyun Liu; Wensheng Huang; Chih-Chin Huang; Young Do Kwon; Robert K Louder; Timothy S Luongo; Jason S McLellan; Marie Pancera; Yongping Yang; Baoshan Zhang; Robin Flinko; James S Foulke; Mohammad M Sajadi; Roberta Kamin-Lewis; James E Robinson; Loïc Martin; Peter D Kwong; Yongjun Guan; Anthony L DeVico; George K Lewis; Marzena Pazgier
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

10.  A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies.

Authors:  Shilei Ding; Maxime Veillette; Mathieu Coutu; Jérémie Prévost; Louise Scharf; Pamela J Bjorkman; Guido Ferrari; James E Robinson; Christina Stürzel; Beatrice H Hahn; Daniel Sauter; Frank Kirchhoff; George K Lewis; Marzena Pazgier; Andrés Finzi
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.